Boundless Bio
Series C
Precision oncology therapeutic
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Founders
P
LinkedIn
Similar Startups
Freenome
Blood test to detect colorectal cancer
Human Longevity
Series B
Early detection for longer life
Kanvas Biosciences
Series A
Gut microbiome for therapeutics
Ceribell
Series C
Point-of-care EEG for seizure triage and treatment optimization
SimpliFed
Series A
Baby breastfeeding virtual care
Janux Therapeutics
Immunotherapy to fight tumors